drugset / Trial / NCT01369745
A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Thus study will test an experimental drug called Z-102 (combination of prednisolone and dipyridamole) to treat patients with moderate to severe rheumatoid arthritis.
Timeline
- Start
- 2011-06
- Primary completion
- 2012-08
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dipyridamole | Other / unclassified | 360 mg | — |
| Comparator | Prednisolone | Other / unclassified | 2.7 mg | — |
| Comparator | Prednisone | Other / unclassified | 5 mg | — |